Response to the letter to the editor Fibrosis or steatosis: which is the best screening target? Comment on the Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity

针对读者来信“纤维化还是脂肪变性：哪个才是最佳筛查目标？”的评论：评述巴西针对超重或肥胖成年人代谢功能障碍相关脂肪肝（MASLD）的循证筛查、诊断、治疗和随访指南。